Combined blockade of PI3K/AKT and EGFR/HER3 enhances antitumor activity in triple negative breast cancer

被引：0
|
作者：
Scaltriti, Maurizio [1 ]
Tao, Jessica [2 ]
Juric, Dejan [2 ]
Auricchio, Neil [2 ]
Castel, Pau [1 ]
Morse, Natasha [1 ]
Kim, Phillip [3 ]
Singh, Sharat [3 ]
Hazra, Saswati [3 ]
Hembrough, Todd [4 ]
Burrows, Jon [4 ]
Baselga, Jose [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
[3] Prometheus Lab Therapeut & Diagnost, San Diego, CA USA
[4] OncoPlexDx, Rockville, MD USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4471
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4471
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Metformin synergistically enhances antitumor activity of cisplatin in gallbladder cancer via the PI3K/AKT/ERK pathway
    Tingting Bi
    Ao Zhu
    Xufeng Yang
    Huiying Qiao
    Jinmei Tang
    Yan Liu
    Rong Lv
    Cytotechnology, 2018, 70 : 439 - 448
  • [32] A PI3Kαδ inhibitor combined with irradiation enhance the effect of PD-1 blockade in syngenic triple negative breast cancer model
    Park, Ji Min
    Lee, Joo Ho
    Kim, Danhyo
    Kim, Eric Eunsik
    Bae, Jun Hyung
    Kim, In Ah
    CANCER RESEARCH, 2019, 79 (13)
  • [33] Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway
    Kumar Ganesan
    Cong Xu
    Jianming Wu
    Bing Du
    Qingqing Liu
    Yue Sui
    Cailu Song
    Jinhui Zhang
    Hailin Tang
    Jianping Chen
    Science China(Life Sciences), 2024, 67 (09) : 1849 - 1866
  • [34] Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway
    Ganesan, Kumar
    Xu, Cong
    Wu, Jianming
    Du, Bing
    Liu, Qingqing
    Sui, Yue
    Song, Cailu
    Zhang, Jinhui
    Tang, Hailin
    Chen, Jianping
    SCIENCE CHINA-LIFE SCIENCES, 2024, 67 (09) : 1849 - 1866
  • [35] Abrogating Metastatic Properties of Triple-Negative Breast Cancer Cells by EGFR and PI3K Dual Inhibitors
    Garcia, Ana Rita
    Mendes, Avilson
    Custodia, Carlos
    Faria, Claudia C.
    Barata, Joao T.
    Malho, Rui
    Figueira, Ines
    Brito, Maria Alexandra
    CANCERS, 2023, 15 (15)
  • [36] Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond
    Sirico, M.
    Jacobs, F.
    Molinelli, C.
    Nader-Marta, Guilherme
    Debien, V.
    Dewhurst, H. Faith
    Palleschi, M.
    Merloni, F.
    Gianni, C.
    De Giorgi, U.
    de Azambuja, Evandro
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 200
  • [37] PI3Kαδ Inhibitor Combined With Radiation Enhances the Antitumor Immune Effect of Anti-PD1 in a Syngeneic Murine Triple-Negative Breast Cancer Model
    Chang, Won Ick
    Han, Min Guk
    Kang, Mi Hyun
    Park, Ji Min
    Kim, Eric Eunshik
    Bae, Junhyung
    Ahn, Soyeon
    Kim, In Ah
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (03): : 845 - 858
  • [38] Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
    不详
    BIOSCIENCE REPORTS, 2024, 44 (07)
  • [39] Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review
    Mehrtabar, Ehsan
    Khalaji, Amirreza
    Pandeh, Mojtaba
    Farhoudian, Aram
    Shafiee, Nadia
    Shafiee, Atefe
    Ojaghlou, Fatemeh
    Mahdavi, Parinaz
    Soleymani-Goloujeh, Mehdi
    MEDICAL ONCOLOGY, 2024, 41 (09)
  • [40] Erianin induces triple-negative breast cancer cells apoptosis by activating PI3K/Akt pathway
    Xu, Yonggang
    Fang, Rong
    Shao, Jie
    Cai, Zihao
    BIOSCIENCE REPORTS, 2021, 41 (04)
12345